High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions
- 1 October 2021
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 26 (10) , 2439-2444
Abstract
No abstract availableKeywords
Funding Information
- Department of Primary Industries
- National Institutes of Health
- National Center for Advancing Translational Sciences
This publication has 37 references indexed in Scilit:
- In vitro methods for testing antiviral drugsBiotechnology Advances, 2018
- Multi-target therapeutics for neuropsychiatric and neurodegenerative disordersDrug Discovery Today, 2016
- Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screenNature Medicine, 2016
- A Quantitative High-Throughput Screening Data Analysis Pipeline for Activity Profiling2016
- Phenotypic screens as a renewed approach for drug discoveryDrug Discovery Today, 2013
- Chemical Genomics Profiling of Environmental Chemical Modulation of Human Nuclear ReceptorsEnvironmental Health Perspectives, 2011
- A Grid Algorithm for High Throughput Fitting of Dose-Response Curve DataCurrent Chemical Genomics, 2010
- Eltrombopag: A Novel Oral Thrombopoietin Receptor AgonistAnnals of Pharmacotherapy, 2010
- A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cellsMolecular Cancer Therapeutics, 2008
- The efficiency of multi-target drugs: the network approach might help drug designTrends in Pharmacological Sciences, 2005